Can't say I disagree
Regardless of whether Calmare is a medical important technology or not, the communications with the shareholders are beyond bizarre
For years, CTTC's official SEC position was that it negotiated an extension on the agreement with Marineo. Shareholders acquired stock based upon this assumption.
Then, two years later, CTTC indicates that they had not negotiated an extension of the agreement. In fact, only the original agreement, which would expire shortly if it was the definitive agreement, is the only one executed. Several members of the board were in place through this whole period of time - including Chairman Peter Brennan. Carl O'Connell was President through most of that period and remains on the Board of Directors. "The vanishing signatures" as it was called is crazy.
So, which shareholders are misled. Current ones who are being told there is an active agreement giving CTTC rights in the US and outside the world? If that is wrong, CTTC faces potential shareholder action.
Or, was it misrepresenting its position publicly for two years before that. It that is the case, CTTC faces potential shareholder action. Who bought stock at $1.50 based on a non-agreement touted by Mr. O'Connell and Mr. Brennan?
Frankly, it looks like either class of shareholder would win a suit.
Rediculous management